21.20.Z - Manufacture of medicines and other pharmaceutical products
10.86.Z - Manufacture of homogenised food preparations and dietetic food
10.89.Z - Manufacture of other food products not elsewhere classified
20.42.Z - Manufacture of perfumes and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical substances
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -59,6 | |||
Gross profit (loss) | 0 | -0,1 | -0,1 | -68,3 |
EBITDA | -67,9 | |||
Short time liabilities | 111,4 | |||
Other operating costs | 3,4 | |||
Equity capital | 0 | -0,1 | -0,2 | -228 |
Operating profit (EBIT) | 0 | -0,1 | -0,1 | 0 |
Assets | 2,1 | 1,7 | 1,7 | -0,5 |
Net profit (loss) | 0 | -0,1 | -0,1 | -68,3 |
Cash | 20 | |||
Net income from sale | 0,8 | 0,4 | 0,3 | -40,3 |
Liabilities and provisions for liabilities | 2,1 | 1,8 | 1,9 | 7,5 |
Working assets | 2,1 | 1,6 | 1,6 | -0,5 |
Other income costs | 469,4 | |||
Depreciation | -3,3 | |||
% | % | % | p.p. | |
Profitability of capital | 1868,7 | |||
Equity capital to total assets | 1 | -3,6 | -11,9 | -8,3 |
Gross profit margin | 4,3 | -19,3 | -54,3 | -35 |
EBITDA Margin | 4,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 8 | |||
Current financial liquidity indicator | -0,2 | |||
Net dept to EBITDA | 0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane